Entasis Therapeutics
- Categories: Life Sciences, Pharmaceutical
- Client: Entasis Therapeutics
Website:
http://www.entasistx.com/
The Chase Group proudly announces the successful completion of a search for the Chief Medical Officer for Entasis Therapeutics. Robin Isaacs, M.D., was hired to lead the early clinical development team for the new company’s pipeline of anti-infective products.
-
The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate… -
The Chase Group Secures Teng Jin Ong for Genmab
Amid an era of rapid growth, Genmab retained The Chase Group to secure a new clinical development medical executive as they work to pioneer the… -
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike… -
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership With The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained… -
Leadership Team Grows at Biologics Consulting Through Partnership With The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,… -
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….